Lung Cancer Epidemiology, Biology, Clinical Presentation and Screening Flashcards

1
Q

One in __ men is expected to
develop lung cancer during
his lifetime and one in __will
die of it.
• One in ___ women is expected
to develop lung cancer during
her lifetime and one in___ is
expected to die of it.

A

One in 11 men is expected to
develop lung cancer during
his lifetime and one in 13 will
die of it.
One in 15 women is expected
to develop lung cancer during
her lifetime and one in 17 is
expected to die of it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

trend of cigarette smoking

A

has been going down. We’ve been seeing drops in lung cancer incidences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Composition
– 80% ___, 20% exhaled “___” smoke
– Some [carcinogens] higher in ___

A

Composition
– 80% sidestream, 20% exhaled “mainstream” smoke
– Some [carcinogens] higher in sidestream

Passive smokers absorb 1-15% of chemicals

• Lung cancer risk of non-smoking wives of
smokers increased 24%
(13-36%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

20% of lung cancers in non-smokers is due to ___

A

environmental tobacco smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lung cancer riskks other than smoking

A

• Air pollution

• Radon (from mining or indoor
exposure) •

Asbestos
– In setting of asbestosis

– Without asbestosis

– Synergy with smoking
• Other “occupational carcinogens”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which vitamin deficiencies are linked to lung cancer

A

vitamins A, C, E and beta carotene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

non neoplastic lung disesase

A

COPD, TB, silicosis, pulmonary fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

outline a few genetic abnormalities specific in lung cancer

A

BRAF

EGFR

Alk fusion

P53 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

outline the 4 major lung cancer

A
  1. small-cell carcinoma (sclc)
  2. non-small cell
    - squamous
    - adenocarcinoma
    - large cell
  3. carcinoid
  4. others
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

types of non-small cell lung cancers

A
  • squamous
  • adenocarcinoma
  • large cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most common non-small cell (nsclc)

A

adenocarcinoma (40%) of lung cancer pathologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

person has long-term dyspnea. On CXR, there are large cavitary regions, with a central lesion involving major airway.

  • on CT, the large cavity was surrounded by gray white granular tissue.
  • this presentation is typical of ___ carcinoma
A

typical of squamous carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a person’s ct demonstrates a peripheral nodule or mass. Which pattern is this consistent wiht?

A

adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which demographics are more at risk for adenocarcinoma

A

Woman / non-smokers

• Associated with
mutations amenable to
sensitive to molecular
treatment modalities

  • this is the most common subtype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

adenocarcinoma demonstrates a ___ growth pattern. what is this?

A

a lepidic growth pattern.

  • slow growth, airspace fisease that is misdiagnosed as pneumonia since it’s on the periphery as a nodeule or mass.
  • can be multifocial, but it preserves lung architecture. might see bronchorrhea.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/f adenocarcinoma preserves lung architecture

A

ture. it’s usually a peripheral nodule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Characteristic symptom of lung adenocarcinoma

A

bronchorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

___ ___ carcinoma demonstrates ___ location, ___ growth and has an increased likelihood of ___ into the hilar lymph nodes.

A

small cell carcinoma: central location, rapid grwoth, and +++ ADENOPATHY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F carcinoid tumors ae more likely to be seen in smokers

A

false. young non-smokers often present with this form of lung cancer.

20
Q

rate of growth in carcinoid tumor. what type of neoplasm does it grow as?

A

slow growting. presents as lung nodule or endobronchial lesion

21
Q

carcinoid tumors are ___ growing and presents as a lung nodule and ___ lesion

A

slow growting. presents as lung nodule or endobronchial lesion

22
Q

a ___ ___ nodule is a lung nodule under 3 cm found on routine CXR. usually asymptomatic

A

solitary pulmonary nodule

23
Q

malignant causes of solitary pulmonary nodule (Lung nodule (<3cm) found on “routine”
CXR, usually asymptomatic)

A
  • bronchogenic carcinoma: adenocarcinoma, squamous cell carcinoma, large cell carcinoma, small cell carcinoma
  • metastatic lesions: breast, head and neck, melanoma, colon, kidney, sarcome, germ cell tumor

- pulmonary carcinoid

24
Q

benign causes of solidary pulmonary nodule

A
  • infetious granulma
  • abscess/cysts
  • benign neoplasms
  • vascular
  • wegeners granulomatosis
25
Q

“clonal evolution” that causes lung canacer development

A
  1. non -malignant genetic changes that predisposes someone to cancer
  2. marker of diffuse tissue injury
  3. development of cloncal patches; bunches of cells with more mutations. sartt to grow abnormally, changes in tumor suppressor genes which become less afected.
  4. you then get frank malignancy. – angiogenesis, invasion, and metastasis starts to occur.
26
Q

for solitary pulmonar nodule (SPN), age correlates with probability of malignancy. outline this trend. Outline other risks

A

50% or higher at age of 60 or above.

  • risks: smoking, previous cancer
27
Q

SPN often are <3cm which are less likely to be malignant, but >3cm has a higher likely hood to be malignant.

What characteristics of SPN lesion indicate a benign vs malignant SPN?

A

– Benign:
Central, diffuse, popcorn or concentric calcification

– Malignant
Irregular or spiculated, eccentric calcification

28
Q

SPN type?

A

benign hamatoma. solitary pulmonary nodule with characteristic popcorn configuration suggestive of a hamartoma

29
Q

SPN type?

A

– Malignant
• Irregular or spiculated, eccentric calcification

30
Q

how is SPN growth characterised?

A
  • based on tumour doubling times of 20-400 days.
  • benign lesions have doubling <20 days or >450 days.
  • doubling refers to volume – not diameter.
31
Q

appraoch to SPN

A
  1. always get old XRAYS
  2. determine probability of malignancy
32
Q

stability of an SPN leesion for <2 years suggests a ___ lesion

A

benign lesion.

33
Q

approach and follow up of solid nodules depending on if the person is high risk or low risk

A

LOW RISK:if under 6mm with one single nodule, no routine follow up is needed. If larger, consider CT at 6-12 months. if over 8mm, consider CT/PET or tissue sampling at 3 months.

HIGH RISK: if under 6mm, optional CT. at 12 months. if 6-8mm, CT at 6-12, then follow up ct at 18 months. if >8mm, consider CT/PET/CT tissue smapling at 3 month

34
Q

follow up/management for gound class,p art solid, or mulitple opacities (SPN)

A

the more solid, the faster the follow up

35
Q

symptoms of lung cancer related to the primary lesion

A

– Cough
– Hemoptysis
– Chest pain
– Dyspnea
– Weezing
– Weight loss

36
Q

mets of lung cancer

A

brain mets, bone mets, liver/adrenal mets

37
Q

pancoast’s syndrome symptoms and causes

A

symptoms associated with a superior pulmonary sulcus tumor.

sx: - shoulder and arm pain, horner’s syndrome, weakness and atrophy of hand muscle

caused by: non-small cell lung cancer, other neoplasms, infectious diseases

38
Q

horner’s syndrome

A

assocaited with pancoast’s syndome; ipsilateral ptosis, miosis, anhidrosis.

39
Q

nail changes in paraneoplastic syndromes

A
  • clubbing
  • hypertropic osteoarthropathy.
40
Q

paaneoplastic syndromes

A
  • hypoercalcemia
  • seen in parathyroid and squamous cell cancers.
  • SIADH (small cell)
  • ectopic ACTH production (small cell)
  • neurological syndromes (small cell)
41
Q

non-Small cell staging vs small cell staging

A

• Non-Small Cell
– Stage I-IV (T N M system)

• Small Cell
– Limited vs. Extensive stage

42
Q

TNM staging for non-small cell staging.

A

T= tumor stages. T1=<3cm, T2= >3cm

N=nodes: mediastinal lymph nodes identified according to international map. N1= ipsilateral lung, N2 = ipsilateral mediastinum. N3= contralateral mediastinum

M = metastasis

43
Q

limited vs extensive small cell lung cancer staging

A

limited= intrathoracic disease. stage IIIB or less. untreated prognosis = 6 month

extensive = extrathoracic disease. stage 4. untreated prognosis 6 weeks.

44
Q

current recommendations on screening for lung cancer.

A
  • lung cacner screening for adults age 55-74 years, with at least a 30 pack year smoking history, who smoke or quit smoking less than 15 years ago, with CT every year for up to 3 years.
45
Q

T/f chest radiology with or without sputum cytology can be used to screen for lung cancer

A

false. only ct and only for adults 77-74 with at least 30 pack year history